KNect365 is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Cell and Gene Therapies Survey 2018: Tell us your views to win a 2-day conference pass


It is an exciting time to be involved in the cell and gene therapy industries. There are both opportunities and challenges around analytical testing, manufacturing, process automation, supply chain, regulations and business deals to name but a few, often still with more questions than answers.

KNect365 Life Sciences is conducting one of the biggest surveys of its kind across cell and gene therapy professionals from pharma, biotechs, academia, CDMOs, service providers and regulators around the world. The final report will reveal unique insights into the state of the cell and gene therapy industries in 2018; the hottest potential opportunities; the biggest challenges and how industry insiders are tackling them.


Click here to take part in the survey

Win a 2-day conference pass...

Completing the survey will take just 5 minutes and will give you exclusive early access to the final report. All answers will remain anonymous. Plus, everyone who completes the survey by Sunday 25th March 2018 will be entered into a prize draw for a free 2-day conference pass to their choice of KNect365 Life Sciences cell and gene therapy conferences (full terms and conditions can be found here):

Cell & Gene Therapy Bioprocessing & Commercialization – 5 - 6 September 2018, Boston, MA
Cell Therapy Manufacturing and Gene Therapy Congress – 4 - 5 December 2018, Amsterdam, The Netherlands
Cell Therapy Manufacturing Asia – 27 February - 2 March 2019, Tokyo, Japan

We’re excited to see the results of this unique study and we hope you are too.

Click here to take part in the survey.

Get articles like this by email